Patient#	Sample#	AP1:(FGFR/FGF/Syndecan-2, active),	IP3:(PI-4-5-P2, active),	Ca2+:(IP3, active),	CBL:(CBL, protein),	CDH2:(CDH2, protein),	CTNND1:(CTNND1, protein),	Cortactin:(Cortactin, protein),	E-cadherin:(E-cadherin, protein),	ERK1-2:(ERK1-2, protein),	FGFR1:(FGFR1, protein),	FGFR2:(FGFR2, protein),	FRS2:(FRS2, protein),	GAB1:(GAB1, protein),	GRB2:(GRB2, protein),	IL17RD:(IL17RD, protein),	KLB:(KLB, protein),	NCAM isoforms:(NCAM isoforms, protein),	PAK4:(PAK4, protein),	NCAM1:(NCAM1, protein),	PDPK1:(PDPK1, protein),	PLAUR:(FGFR-FGF2 complex, active),(PLAUR, protein),	PLCG1:(FGFR/FGF/Syndecan-2, active),(PLCG1, protein),	PTK2B:(PTK2B, protein),	SHC1:(SHC1, protein),	SHP2:(SHP2, protein),	SOS1:(SOS1, protein),	SPP1:(SPP1, protein),	SPRY2:(SPRY2, protein),	STAT1:(FGFR/FGF/Syndecan-2, active),(STAT1, protein),	STAT5B:(STAT5B, protein),	SRC:(SRC, protein),	CaMKIIA:(Ca2+, active),(CaMKIIA, protein),	DAG:(PI-4-5-P2, active),(PLCG1, active),	ERK1-2-active:(E-cadherin, active),(ERK1-2, active),(ERK1-2-active, protein),(FGFR-FGF2 complex, active),	FGFR1-FGF complex:(CTNND1, active),(E-cadherin, active),	FGFR1/NCAM:(ATP, active),(FGFR1, active),(NCAM1, active),	FGFR2/NCAM:(ATP, active),(FGFR2, active),(NCAM1, active),	FGFR2b/FGF1/PAK4/GRB2:(FGFR2b/FGF1, active),(GRB2, active),(PAK4, active),	FGFR3-FGF complex/Pyk2:(FGFR3-FGF complex, active),(PTK2B, active),(SHP2, active),	FGFR4-FGF complex/NCAM:(FGFR4-FGF complex, active),(NCAM1, active),	FGFR4/FGF19/Klotho:(FGFR4/FGF19, active),(KLB, active),	PYK2/SHP2:(FGFR3-FGF complex, active),(PTK2B, active),(SHP2, active),	CDH1:(CDH1, protein),(CTNND1, active),(FGFR1-FGF complex, active),	FGFR-FGF2 complex/N-cadherin:(CDH2, active),(FGFR-FGF2 complex, active),	FGFR1-FGF complex/NCAM isoforms:(FGFR1-FGF complex, active),(NCAM isoforms, active),	FGFR1-FGF complex/Sef:(FGFR1-FGF complex, active),(IL17RD, active),	FGFR1-FGF complex/Src/Cortactin:(Cortactin, active),(FGFR1-FGF complex, active),(SRC, active),(senescence, active),	FGFR3c/FGF23/Klotho:(FGFR3c/FGF23, active),(KLB, active),	RPS6KA1:(ERK1-2-active, active),(RPS6KA1, protein),	STAT5B (dimer):(FGFR3-FGF complex/Pyk2, active),(STAT5B, active),	cytoskeleton organization:(CaMKIIA, active),	negative regulation of apoptosis:(FGFR2b/FGF1/PAK4/GRB2, active),	FGFR/FGF/Syndecan-2/FRS2:(ERK1-2-active, active),(FGFR/FGF/Syndecan-2, active),(FRS2, active),	RUNX2:(ERK1-2-active, active),(RUNX2, protein),	negative regulation of receptor internalization:(FGFR-FGF2 complex/N-cadherin, active),	FGFR/FGF/Syndecan-2/FRS2/Sprouty2:(FGFR/FGF/Syndecan-2/FRS2, active),(SPRY2, active),(SRC, active),	SHP2/GAB/GRB2/FRS2/FGFR/FGF/Syndecan-2:(FGFR/FGF/Syndecan-2/FRS2, active),(GAB1, active),(GRB2, active),(SHP2, active),	FGFR/FGF/Syndecan-2/FRS2/Sprouty2/Cbl:(CBL, active),(FGFR/FGF/Syndecan-2/FRS2/Sprouty2, active),	FGFR/FGF/Syndecan-2/FRS2/Sprouty2/Grb2:(FGFR/FGF/Syndecan-2/FRS2, active),(FGFR/FGF/Syndecan-2/FRS2/Sprouty2, active),(GRB2, active),(SHC1, active),(SOS1, active),	Grb2/SOS1/SHC/FRS2/FGFR/FGF:(FGFR/FGF/Syndecan-2/FRS2, active),(FGFR/FGF/Syndecan-2/FRS2/Sprouty2, active),(GRB2, active),(SHC1, active),(SOS1, active),	MMP9_107-707:(MMP9_107-707, protein),	PI3K:(SHP2/GAB/GRB2/FRS2/FGFR/FGF/Syndecan-2, active),	BGLAP:(BGLAP, protein),	FGFR/FGF/Syndecan-2/FRS2/Cbl/GRB2/SOS1/SHC:(CBL, active),(Grb2/SOS1/SHC/FRS2/FGFR/FGF, active),	MAPKKK cascade:(ERK1-2-active, active),(FGFR1-FGF complex/Sef, active),(Grb2/SOS1/SHC/FRS2/FGFR/FGF, active),	PI-3-4-5-P3:(PI-4-5-P2, active),(PI3K, active),	AKT1:(AKT1, protein),(PDPK1, active),(PI-3-4-5-P3, active),	degradation:(FGFR/FGF/Syndecan-2/FRS2/Cbl/GRB2/SOS1/SHC, active),	uPA:(FGFR-FGF2 complex, active),(uPA, protein),	cell migration:(FGFR1-FGF complex/Src/Cortactin, active),(HGF/MET, active),(PLAUR, active),(uPA, active),	
